Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuyoshi Matsuoka

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Immunological Medicine|July 15, 2020
Fecal microbiota transplantation for ulcerative colitisKatsuyoshi Matsuoka
Intestinal Research|June 3, 2020
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel diseaseKatsuyoshi Matsuoka
Seminars in Immunopathology|November 26, 2014
The gut microbiota and inflammatory bowel diseaseKatsuyoshi Matsuoka, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2023
[Progress in monitoring methods for inflammatory bowel disease]Kentaro Nakamura, Katsuyoshi Matsuoka
Digestion|June 26, 2013
Mechanism and therapeutic strategy of secondary failure to anti-tumor necrosis factor-α monoclonal antibody treatment for Crohn's diseaseKatsuyoshi Matsuoka, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 13, 2020
[Effectiveness and limitations of thiopurines as remission maintenance therapy after calcineurin inhibitor treatment in ulcerative colitis]Akihiro Yamada, Katsuyoshi Matsuoka
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 8, 2016
Ulcerative colitis -recent advance in clinical practice and basic researchKatsuyoshi Matsuoka, Mamoru Watanabe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2011
[Viral infection of the small intestine]Katsuyoshi Matsuoka, Toshifumi Hibi
Nature Reviews. Gastroenterology & Hepatology|May 23, 2023
Etrasimod for ulcerative colitis: evaluating phase III resultsKatsuyoshi Matsuoka, Toshifumi Hibi
Nature Reviews. Gastroenterology & Hepatology|July 3, 2023
Author Correction: Etrasimod for ulcerative colitis: evaluating phase III resultsKatsuyoshi Matsuoka, Toshifumi Hibi
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Immunological Medicine|July 15, 2020
Fecal microbiota transplantation for ulcerative colitisKatsuyoshi Matsuoka
Intestinal Research|June 3, 2020
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel diseaseKatsuyoshi Matsuoka
Seminars in Immunopathology|November 26, 2014
The gut microbiota and inflammatory bowel diseaseKatsuyoshi Matsuoka, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2023
[Progress in monitoring methods for inflammatory bowel disease]Kentaro Nakamura, Katsuyoshi Matsuoka
Digestion|June 26, 2013
Mechanism and therapeutic strategy of secondary failure to anti-tumor necrosis factor-α monoclonal antibody treatment for Crohn's diseaseKatsuyoshi Matsuoka, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 13, 2020
[Effectiveness and limitations of thiopurines as remission maintenance therapy after calcineurin inhibitor treatment in ulcerative colitis]Akihiro Yamada, Katsuyoshi Matsuoka
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 8, 2016
Ulcerative colitis -recent advance in clinical practice and basic researchKatsuyoshi Matsuoka, Mamoru Watanabe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2011
[Viral infection of the small intestine]Katsuyoshi Matsuoka, Toshifumi Hibi
Nature Reviews. Gastroenterology & Hepatology|May 23, 2023
Etrasimod for ulcerative colitis: evaluating phase III resultsKatsuyoshi Matsuoka, Toshifumi Hibi
Nature Reviews. Gastroenterology & Hepatology|July 3, 2023
Author Correction: Etrasimod for ulcerative colitis: evaluating phase III resultsKatsuyoshi Matsuoka, Toshifumi Hibi
Pageof 21